Karyopharm Therapeutics | Lånekapital

Loan Capital Endring Dato
AbbVie USD 55.63B 181M 2023-09
Amgen USD 63.17B 4.13B 2023-12
AstraZeneca USD 22.97B 2.08B 2023-09
Bristol-Myers Squibb USD 32.14B 2.52B 2023-09
Eli Lilly USD 17.92B 956.9M 2023-09
Enanta Pharmaceuticals USD 1.42M 0 2023-09
GlaxoSmithKline GBP 15.99B 440M 2023-09
Incyte USD 29.16M 303K 2023-12
MacroGenics USD 0 0 2022-06
Merck USD 33.97B 100M 2023-09
Nektar Therapeutics USD 0 0 2022-06
Pfizer USD 61.05B 308M 2023-09
Regeneron Pharmaceuticals USD 2.7B 300K 2023-12
Roche Holding CHF 20.35B 1.05B 2023-06
Sangamo BioSciences USD 0 0 2022-06
Takeda JPY 4.4T 74.11B 2023-09
TG Therapeutics USD 98.91M 1.21M 2023-09
Ultragenyx Pharmaceutical USD 0 0 2022-06
Xencor USD 14.64M 14.64M 2023-12



Karyopharm Therapeutics Lånekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.